
|Podcasts|February 23, 2022
The changing landscape of gene therapy and standardized endpoints
Author(s)David Hutton
In this episode of EyePod, Ora Clinical’s Keith Lane offers a brief overview of the current state of ophthalmology and its standardized endpoints. He also discusses some of the challenges that gene therapy has faced, particularly in relation to ophthalmology. He also offers his outlook for the future of gene therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
3
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
4
Detecting peripheral retinal lesions in children with myopia
5
























